Charles Paulding

3.3k total citations
15 papers, 1.1k citations indexed

About

Charles Paulding is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Charles Paulding has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Immunology. Recurrent topics in Charles Paulding's work include Pharmacogenetics and Drug Metabolism (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Charles Paulding is often cited by papers focused on Pharmacogenetics and Drug Metabolism (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Charles Paulding collaborates with scholars based in United States, France and Switzerland. Charles Paulding's co-authors include Daniel A. Haber, Maryellen Ruvolo, Steve Lewitzky, Jonathan B. Singer, Xiao‐Jun Zhao, Fan Yang, Elisabeth Leroy, Lloyd B. Klickstein, Timothy M. Wright and Joanne M. Meyer and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Charles Paulding

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Paulding United States 9 583 210 200 193 112 15 1.1k
Linda S. Wood United States 20 392 0.7× 129 0.6× 283 1.4× 216 1.1× 104 0.9× 45 1.2k
Jaideep V. Thottassery United States 18 570 1.0× 151 0.7× 565 2.8× 205 1.1× 73 0.7× 31 1.2k
Bradford A. Young United States 15 458 0.8× 124 0.6× 148 0.7× 29 0.2× 118 1.1× 20 1.1k
Nur Buyru Türkiye 18 605 1.0× 158 0.8× 291 1.5× 45 0.2× 31 0.3× 63 1.0k
Sonal Patel United States 14 397 0.7× 34 0.2× 325 1.6× 124 0.6× 70 0.6× 25 845
Jing He United States 16 532 0.9× 71 0.3× 264 1.3× 28 0.1× 40 0.4× 54 996
Guillermo Pita Spain 20 427 0.7× 217 1.0× 350 1.8× 38 0.2× 134 1.2× 42 1.1k
Motoi Kondo Japan 20 419 0.7× 108 0.5× 433 2.2× 55 0.3× 35 0.3× 37 1.3k
Hisataka Shikama Japan 16 327 0.6× 130 0.6× 121 0.6× 30 0.2× 43 0.4× 28 807
Gitte Hoffmann Bruun Denmark 14 528 0.9× 69 0.3× 176 0.9× 90 0.5× 41 0.4× 17 862

Countries citing papers authored by Charles Paulding

Since Specialization
Citations

This map shows the geographic impact of Charles Paulding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Paulding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Paulding more than expected).

Fields of papers citing papers by Charles Paulding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Paulding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Paulding. The network helps show where Charles Paulding may publish in the future.

Co-authorship network of co-authors of Charles Paulding

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Paulding. A scholar is included among the top collaborators of Charles Paulding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Paulding. Charles Paulding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Guymer, Robyn H., Rufino Silva, Mercedeh Ghadessi, et al.. (2024). ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2. Investigative Ophthalmology & Visual Science. 65(8). 17–17. 2 indexed citations
2.
Lin, Nan, Amy Damask, Anita Boyapati, et al.. (2022). UGT1A1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab. The Pharmacogenomics Journal. 22(3). 160–165. 2 indexed citations
3.
Murphy, William A., Nan Lin, Amy Damask, et al.. (2022). Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial. Circulation Genomic and Precision Medicine. 15(3). e003503–e003503. 8 indexed citations
4.
Bienfait, Karina, Aparna Chhibber, Jean‐Claude Marshall, et al.. (2021). Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG). Human Genetics. 141(6). 1165–1173. 20 indexed citations
5.
Damask, Amy, Philippe Gabríel Steg, Gregory G. Schwartz, et al.. (2019). Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial. Circulation. 141(8). 624–636. 146 indexed citations
6.
7.
Damask, Amy, Anita Boyapati, Sara Hamon, et al.. (2017). FRI0228 Ugt1a1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab. Annals of the Rheumatic Diseases. 76. 570–571. 2 indexed citations
8.
Yelensky, Roman, Steve Lewitzky, Elizabeth C. LeRoy, et al.. (2011). A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients. The Pharmacogenomics Journal. 12(6). 484–488. 11 indexed citations
9.
Singer, Jonathan B., Steve Lewitzky, Elisabeth Leroy, et al.. (2010). A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nature Genetics. 42(8). 711–714. 273 indexed citations
10.
Paulding, Charles, Jonathan B. Singer, Steve Lewitzky, et al.. (2010). OC-036 A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Gut. 59(Suppl 1). A15.2–A15. 1 indexed citations
11.
12.
Yajnik, Vijay, Charles Paulding, Raffaella Sordella, et al.. (2003). DOCK4, a GTPase Activator, Is Disrupted during Tumorigenesis. Cell. 112(5). 673–684. 194 indexed citations
13.
Paulding, Charles, Maryellen Ruvolo, & Daniel A. Haber. (2003). The Tre2 ( USP6 ) oncogene is a hominoid-specific gene. Proceedings of the National Academy of Sciences. 100(5). 2507–2511. 121 indexed citations
14.
Lee, Sean Bong, Karen Huang, Rachel Palmer, et al.. (1999). The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin. Cell. 98(5). 663–673. 241 indexed citations
15.
Paulding, Charles, et al.. (1995). Multiple Changes in E2F Function and Regulation Occur upon Muscle Differentiation. Molecular and Cellular Biology. 15(4). 2252–2262. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda S. Wood Breakdown of academic impact, for papers by Jaideep V. Thottassery Breakdown of academic impact, for papers by Bradford A. Young Breakdown of academic impact, for papers by Nur Buyru Breakdown of academic impact, for papers by Sonal Patel Breakdown of academic impact, for papers by Jing He Breakdown of academic impact, for papers by Guillermo Pita Breakdown of academic impact, for papers by Motoi Kondo Breakdown of academic impact, for papers by Hisataka Shikama Breakdown of academic impact, for papers by Gitte Hoffmann Bruun
Rankless by CCL
2026